Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Bayer AG

Start price
Target price
Perf. (%)
€46.63
12.12.20
-
12.12.21
17.84%
16.02.21

Higher risks for its business
Increased challenges to pay loans and raise capital
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€35.01
12.12.20
-
12.12.21
-14.23%
24.03.21

Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
buy
Deutsche Lufthansa AG

Start price
Target price
Perf. (%)
€9.35
12.12.20
-
12.12.21
18.32%
24.03.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Home Depot Inc.

Start price
Target price
Perf. (%)
€218.45
12.12.20
-
12.12.21
12.86%
24.03.21

Fair valuation
High dividend yield expected
Valuable balance sheet
Little Investments for future growth
Overstock.com

Start price
Target price
Perf. (%)
€45.56
12.12.20
-
12.12.21
74.51%
08.02.21

Stable Large shareholder and/or long term investor
EBIT decline/stagnation expected
Few uniques
Sustainability is little important
Envveno Medical Corp.

Start price
Target price
Perf. (%)
€10.03
12.12.20
€4.00
12.12.21
-45.01%
26.06.21

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
vTv Therapeutics Inc

Start price
Target price
Perf. (%)
€2.30
12.12.20
€1.00
12.12.21
-14.22%
26.06.21

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
overvalued
Sonoma Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€6.90
12.12.20
€3.00
12.12.21
-8.48%
26.06.21

Risky Investment
Revenue decline > 20% expected
Decining EBIT margin than peer group
EBIT decline > 20% expected
aTyr Pharma Inc

Start price
Target price
Perf. (%)
€3.78
12.12.20
€2.00
12.12.21
4.76%
26.06.21

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Rainforest Resources Inc.

Start price
Target price
Perf. (%)
€2.08
12.12.20
-
7.69%
15.12.20

Risky Investment
Business model of the past or high risk
Little known brand
buy
Adyen NV ADR

Start price
Target price
Perf. (%)
€36.40
12.12.20
-
2.20%
15.12.20

Revenue growth >5% per year expected
Valuable balance sheet
Capable Management
buy
Amazon.com Inc.

Start price
Target price
Perf. (%)
€128.58
11.12.20
€183.95
11.12.21
13.77%
04.11.21

Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Very capable Management
Very good company culture
buy
E.ON SE

Start price
Target price
Perf. (%)
€8.85
11.12.20
€10.00
1.33%
13.12.20

Could be worthwhile Investment >10% per year
buy
Fuchs Petrolub SE ST

Start price
Target price
Perf. (%)
€45.56
11.12.20
€48.00
5.22%
17.12.20

Could be worthwhile Investment >10% per year
Known brand
Good culture
buy
E.ON SE

Start price
Target price
Perf. (%)
€8.89
11.12.20
€11.00
-0.43%
11.12.20

Could be worthwhile Investment >10% per year
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€392.75
11.12.20
€250.00
0.97%
11.12.20

Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
buy
Invitae Corp

Start price
Target price
Perf. (%)
€48.87
11.12.20
€50.00
-14.92%
17.12.20

Ballard Power Systems Inc.

Start price
Target price
Perf. (%)
€15.85
11.12.20
-
11.12.21
0.22%
11.12.20

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Capable Management
High valuation
buy
Fiat Chrysler Automobiles NV

Start price
Target price
Perf. (%)
€13.55
11.12.20
-
9.92%
03.01.21

buy
Barrick Gold Corp

Start price
Target price
Perf. (%)
€19.14
11.12.20
€20.00
-0.38%
22.01.21

Future proof or reliable business model
Higher EBIT margin than peer group
positive Cash Flow expected
Good rating
buy
Lenzing AG

Start price
Target price
Perf. (%)
€75.00
11.12.20
€140.00
58.40%
05.03.21

Known brand
Could be worthwhile Investment >10% per year
Small cyclical dependencies
Future proof or reliable business model
Meta Platforms Inc.

Start price
Target price
Perf. (%)
€226.65
11.12.20
€200.00
0.29%
14.12.20

Top 10 in its market
Revenue growth >5% per year expected
Good rating
Some uniques
buy
Bluestone Resources Inc.

Start price
Target price
Perf. (%)
€1.27
11.12.20
€2.00
11.12.21
4.25%
12.12.21

Could be very worthwhile Investment >20% year
Splunk Inc.

Start price
Target price
Perf. (%)
€125.96
10.12.20
€119.00
10.12.21
5.00%
21.12.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
SPI Energy Co Ltd ADR

Start price
Target price
Perf. (%)
€6.65
10.12.20
€6.00
10.12.21
0.00%
22.12.20

Valuable balance sheet
Capable Management
Sustainability is not important
ROE lower than 10% per year